 Shares of Pear Therapeutics Inc NASDAQ: PEAR closed up nearly 25 on Monday after BTIG said the Boston-headquartered company was the best positioned in the prescription digital therapeutics PDT space. BTIGs Marie Thibault sees a 60 upside On Monday, analyst Marie Thibault assumed coverage of the stock with a buy rating and a price target ... The post Pear Therapeutics closed up 25 on Monday: explained here appeared first on Invezz. 